Zhixi Li1, Ran Liu1,2, Ou Xiao1, Xinxing Guo1,3, Decai Wang1, Jian Zhang1, Jason James Ha4, Jonathan Tak Loong Lee5, Peiying Lee5, Monica Jong6, Padmaja Sankaridurg6, Kyoko Ohno-Matsui7, Mingguang He1,5. 1. State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China. 2. New England College of Optometry, Boston, Massachusetts, United States. 3. Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, United States. 4. Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia. 5. Centre for Eye Research Australia, Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia. 6. Brien Holden Vision Institute, Sydney, New South Wales, Australia. 7. Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.
Abstract
Purpose: To evaluate the 2-year changes in myopic maculopathy and its associations in highly myopic eyes. Methods: This was a longitudinal, observational cohort study involving 657 Chinese participants with bilateral high myopia (≤ -6.00 diopters spherical power), who were followed for 2 years. The worst eye of each participant was considered for the analysis. Myopic maculopathy was graded based on fundus photographs, using the International Photographic Classification and Grading System for Myopic Maculopathy. Results: The mean baseline age was 21.6 ± 12.2 years (range, 6.8-69.7 years). Myopic maculopathy progressed in 97 (14.8%) of 657 eyes, of which 24 eyes progressed to a higher category of myopic maculopathy, including from no maculopathy to tessellated fundus in 17 eyes, from tessellated fundus to diffuse atrophy in 6 eyes, and from diffuse to patchy atrophy in 1 eye. Among 122 lesion changes identified, the most common changes were enlargement of diffuse atrophy (n = 50, 41.0%), appearance of lacquer cracks (n = 28, 23.0%), enlargement of patchy atrophy (n = 10, 8.2%) and development of additional lacquer cracks (n = 7, 5.8%). In addition, we identified 1 eye with enlargement of a Fuch's spot, and 1 eye with active choroidal neovascularization. In multiple logistic regression analysis, myopic maculopathy progression was associated with older age, longer axial length, greater change in myopic spherical equivalent and more severe myopic maculopathy at baseline. Conclusions: Myopic maculopathy progressed in approximately 15% of highly myopic eyes over a 2-year period. Further studies with longer follow up periods are required to confirm identified risk factors for progression.
Purpose: To evaluate the 2-year changes in myopic maculopathy and its associations in highly myopic eyes. Methods: This was a longitudinal, observational cohort study involving 657 Chinese participants with bilateral high myopia (≤ -6.00 diopters spherical power), who were followed for 2 years. The worst eye of each participant was considered for the analysis. Myopic maculopathy was graded based on fundus photographs, using the International Photographic Classification and Grading System for Myopic Maculopathy. Results: The mean baseline age was 21.6 ± 12.2 years (range, 6.8-69.7 years). Myopic maculopathy progressed in 97 (14.8%) of 657 eyes, of which 24 eyes progressed to a higher category of myopic maculopathy, including from no maculopathy to tessellated fundus in 17 eyes, from tessellated fundus to diffuse atrophy in 6 eyes, and from diffuse to patchy atrophy in 1 eye. Among 122 lesion changes identified, the most common changes were enlargement of diffuse atrophy (n = 50, 41.0%), appearance of lacquer cracks (n = 28, 23.0%), enlargement of patchy atrophy (n = 10, 8.2%) and development of additional lacquer cracks (n = 7, 5.8%). In addition, we identified 1 eye with enlargement of a Fuch's spot, and 1 eye with active choroidal neovascularization. In multiple logistic regression analysis, myopic maculopathy progression was associated with older age, longer axial length, greater change in myopic spherical equivalent and more severe myopic maculopathy at baseline. Conclusions: Myopic maculopathy progressed in approximately 15% of highly myopic eyes over a 2-year period. Further studies with longer follow up periods are required to confirm identified risk factors for progression.
Authors: Feng Bin Lin; Shi Da Chen; Yun He Song; Wei Wang; Ling Jin; Bing Qian Liu; Yu Hong Liu; Mei Ling Chen; Kai Gao; David S Friedman; Jost B Jonas; Tin Aung; Lin Lv; Yi Zhi Liu; Xiu Lan Zhang Journal: Trials Date: 2020-09-29 Impact factor: 2.279